Dipivefrine

This article is about the drug. It is not to be confused with Propyne.
Dipivefrine
Systematic (IUPAC) name
[2-(2,2-dimethylpropanoyloxy)-4- (1-hydroxy-2-methylamino-ethyl)- phenyl] 2,2-dimethylpropanoate
Clinical data
Trade names Propine
AHFS/Drugs.com International Drug Names
MedlinePlus a686005
Pregnancy
category
  • US: B (No risk in non-human studies)
Identifiers
CAS Number 52365-63-6 YesY
ATC code S01EA02 (WHO)
PubChem CID 3105
IUPHAR/BPS 7166
DrugBank DB00449 YesY
ChemSpider 2994 YesY
UNII 8Q1PVL543G YesY
KEGG D02349 YesY
ChEBI CHEBI:4646 YesY
ChEMBL CHEMBL1201262 N
Chemical data
Formula C19H29NO5
Molar mass 351.437 g/mol
 NYesY (what is this?)  (verify)

Dipivefrin (trade name Propine) is a prodrug of epinephrine, and is used to treat open-angle glaucoma.[1] It is available as a 0.1% ophthalmic solution.

Mechanism of action

The drug when applied over the cornea, penetrates it and is then hydrolysed to epinephrine by the esterases. It increases uveo-scleral outflow and also reduces aqueous formation (an α1 and α2 mediated action), thus reducing the intraocular pressure. It also increases the hydraulic conductivity of trabecular filtering cells (a β2 mediated action). It is preferred to epinephrine because it is longer acting, more consistent in its action and has better ocular tolerance.[1]

References

  1. 1 2 KD Tripari MD. Essentials of Medical Pharmacology (5 ed.). Jaypee Brothers Medical Publishers(P) Ltd. p. 88. ISBN 81-8061-187-6.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.